" In addition to our commercially available products, Vitro Biopharma also owns proprietary intellectual property related to specific inventions and medical applications. We own intellectual property related to treatment of infertility through the production and purification of the pituitary hormone, FSH which is a well-known fertility drug that has been used since the 1960’s to treat infertility. During 2011, Vitro Biopharma entered into a license agreement with Dr. James Posillico, a world renowned authority in women’s health care, covering the Company’s intellectual property related to treatment of infertility. The Company also owns an issued US Patent for a stem cell line with application to treatment of diabetes in humans and animals. This technology is at advanced preclinical levels and is available for partnering into commercial products. Vitro Biopharma also owns a pending patent application related to novel methods for generation of induced-pluripotent stem cells from adult stem cells. The Company owns addition proprietary technology for formulation of chemically-defined, serum and animal-component free cell culture media together with early pre-clinical technology with application to treatment of hearing loss. "
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.